People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Banquy, Xavier
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (5/5 displayed)
- 2024Bioinspired Bottlebrush Polymers Effectively Alleviate Frictional Damage Both in Vitro and in Vivocitations
- 2024Layer‐by‐Layer Deposition of a Polycationic Bottlebrush Polymer with Hyaluronic Acid Reveals Unusual Assembly Mechanism and Selective Effect on Cell Adhesion and Fatecitations
- 2023New trends for osteoarthritis: Biomaterials, models and modelingcitations
- 2023Bottlebrush polymer with dual functionality for osteoarthritis treatment: curcumin delivery and lubrication propertiescitations
- 2018Lubrication and Wear Protection of Micro-Structured Hydrogels Using Bioinspired Fluidscitations
Places of action
Organizations | Location | People |
---|
article
New trends for osteoarthritis: Biomaterials, models and modeling
Abstract
The burden of osteoarthritis (OA), one of the major causes of functional disabilities in humans and animals, continues to increase worldwide while no disease-modifying OA drugs (DMOADs) that either slow down or reverse disease progression have been made available. Here, we provide a brief overview of recent advances in: designing new OA drug delivery approaches, focusing on lubrication-based biomaterials and drug delivery systems, such as hydrogels, liposomes, dendrimers, micro- and nanoparticles; using either large (horse) or small (zebrafish) relevant animal models to evaluate new therapeutic strategies; and OA in vitro modeling, focusing on 3D (organoid) models of cartilage regarding the Replace, Reduce and Refine (3R) principle of animal experimentation.